Toxoplasmosis in a woman with lymphadenopathy
https://doi.org/10.51523/2708-6011.2024-21-2-17
Abstract
Toxoplasmosis is an infectious disease, the causative agent of which is Toxoplasma gondii - the simplest, intracellular parasite, which infects up to a third of the world’s population.
Clinical manifestations of toxoplasmosis in immunocompetent patients are characterized by lymphadenopathy syndrome, high level of specific antibodies and a favorable outcome. At the same time, the enlargement of the lymph nodes requires a multidimensional differential diagnosis to exclude other diseases.
The article presents a clinical case of toxoplasmosis in a woman with lymphadenopathy. The role of the histological evaluation in the study of biopsy of the lymph nodes in toxoplasmosis was demonstrated. The analysis of literature sources, clinical data, results of laboratory and instrumental studies was carried out.
About the Authors
E. M. Jandarova
Gomel State Medical University
Belarus
Belarus
lena M. Jandarova, Assistant at the Department of Internal Medicine No. 1 with the courses of Endocrinology and Hematology
Gomel
D. I. Haurylenka
Republican Scientific and Practical Center for Radiation Medicine and Human Ecology
Belarus
Belarus
Dzmitry I. Haurylenka, Candidate of Medical Sciences, Head of the Department of Functional Diagnostics
Gomel
M. Yu. Zhandarau
Republican Scientific and Practical Center for Radiation Medicine and Human Ecology
Belarus
Belarus
Michael Yu. Zhandarau, Pathologist
Gomel
E. G. Malaeva
Gomel State Medical University
Belarus
Belarus
Ekaterina G. Malaeva, Candidate of Medical Sciences, Associate Professor, Head of the Department of Internal Diseases No.1 with the courses of Endocrinology and Hematology
Gomel
O. F. Soroko
Gomel State Medical University
Belarus
Belarus
Oksana F. Soroko, Assistant at the Department of Environmental and Preventive Medicine
Gomel
T. A. Kurman
Gomel State Medical University
Belarus
Belarus
Tatyana A. Kurman, Senior Lecturer at the Department of Internal Medicine No. 1 with the courses of Endocrinology and Hematology
Gomel
References
1. Liu Y, Chen J, Zhang C, Li Q, Zhou H, Zeng Y, et al. Ultrasound-Based Radiomics Can Classify the Etiology of Cervical Lymphadenopathy: A Multi-Center Retrospective Study. Front Oncol. 2022 May 17;12:856605. DOI: https://doi.org/10.3389/fonc.2022.856605
2. Naumova AS, Tiganova OA, Ilyenko LI. Cervical lymphadenopathy is a diagnostic challenge. Pediatric otorhinolaryngology. 2019;(3):34-39.
3. Povzun SA. Productive inflammation. A guide for doctors. SpecialLit. 2018. 359 p.
4. Ybañez RHD, Ybañez AP, Nishikawa Y. Review on the Current Trends of Toxoplasmosis Serodiagnosis in Humans. Front Cell Infect Microbiol. 2020 May 8;10:204. DOI: https://doi.org/10.3389/fcimb.2020.00204
5. Suvorova VN, Belkina EI. Toxoplasmosis Agro-industrial complex: contours of the future. In: Materials of the IX International Scientific and Practical Conference of Students, Postgraduate Students and Young Scientists; 2017, December 6-8; Kursk Kursk: Kursk State Agricultural Academy named after. Professor I.I. Ivanova; 2018;1:296-299.
6. Tursunbaeva AT, Muidinov FF. Features of the course of toxoplasmosis in women. Bulletin of Osh State University. 2020;(1-5):152-155.
7. Ivanov VA, Tereshkina SYu, Savchenkova DA. Etiology, pathogenesis, clinical picture, prevention and treatment of toxoplasmosis. Integrative trends in medicine and education. 2022;(3):63-69.
8. Gaulin C, Ramsay D, Thivierge K, Tataryn J, Courville A, Martin C, Cunningham P, Désilets J, Morin D, Dion R. Acute Toxoplasmosis among Canadian Deer Hunters Associated with Consumption of Undercooked Deer Meat Hunted in the United States. Emerg Infect Dis. 2020 Feb;26(2):199-205. DOI: https://doi.org/10.3201/eid2602.191218
9. Daher D, Shaghlil A, Sobh E, Hamie M, Hassan ME, Moumneh MB, Itani S, El Hajj R, Tawk L, El Sabban M, El Hajj H. Comprehensive Overview of Toxoplasma gondii-Induced and Associated Diseases. Pathogens. 2021 Oct 20;10(11):1351. DOI: https://doi.org/10.3390/pathogens10111351
10. Aguirre AA, Longcore T, Barbieri M, Dabritz H, Hill D, Klein PN, Lepczyk C, Lilly EL, McLeod R, Milcarsky J, Murphy CE, Su C, VanWormer E, Yolken R, Sizemore GC. The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention Strategies. Ecohealth. 2019 Jun;16(2):378-390. DOI: https://doi.org/10.1007/s10393-019-01405-7
11. Sanchez SG, Besteiro S. The pathogenicity and virulence of Toxoplasma gondii. Virulence. 2021 Dec;12(1):3095-3114. DOI: https://doi.org/10.1080/21505594.2021.2012346
12. Webster JP, McConkey GA. Toxoplasma gondii-altered host behaviour: clues as to mechanism of action. Folia Parasitol (Praha). 2010 Jun 57(2):95-104. DOI: https://doi.org/10.14411/fp.2010.012
13. Stepanova EV, Kondrashin AV, Godkov MA, Bazhenov AI, Brazhnikov AYu, Sergiev VP. Proposed consequences of targeted modulation of human behavior under the influence of Toxoplasma gondii. Medical parasitology and parasitic diseases. 2015;(3):8-12.
14. Flegr J, Zitkova S, Kodym P, Frynta D. Induction of changes in human behavior by the parasitic protozoan Toxoplasma gondii. Parasitology. 1996;113:49-54.
15. Mitsura VM. Modern serological diagnosis of toxoplasmosis: a review of the literature. Clinical infectology and parasitology. 2022;11(3):210-217. DOI: https://doi.org/10.34883/PI.2022.11.3.028
16. Lapinskas PJ, Ben-Harari RR. Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis. Postgrad Med. 2019 Nov;131(8):589-596. DOI: https://doi.org/10.1080/00325481.2019.1655258
17. Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice. Clin Microbiol Rev. 2018 Sep 12;31(4):e00057-17. DOI: https://doi.org/10.1128/CMR.00057-17
Review
For citations:
Jandarova E.M., Haurylenka D.I., Zhandarau M.Yu., Malaeva E.G., Soroko O.F., Kurman T.A. Toxoplasmosis in a woman with lymphadenopathy. Health and Ecology Issues. 2024;21(2):147-154. (In Russ.) https://doi.org/10.51523/2708-6011.2024-21-2-17
Views: 236
Email this article 